By adding Parafilm M to its portfolio, Avantor India enables customers to source the product alongside chemicals, reagents, ...
For decades, the complexity of the brain, limited understanding of disease biology and the formidable blood-brain barrier ...
On March 13, 2026, China’s National Medical Products Administration (NMPA) granted Class III registration to NEO, an ...
Now, the technology is making headlines again in cancer treatment. For the first time, a personalised mRNA cancer vaccine has ...
For instance, in March 2026, China’s National Medical Products Administration (NMPA) announced approval of the country's ...
AABB has published a special TRANSFUSION journal supplement examining the growing biotherapies landscape, including cell and ...
The bottleneck is the specialist appointment More than 240 million people aged 65 and over live in the Western Pacific, a ...
International healthcare leaders should view Taiwan as a top-tier innovator of complete, end-to-end clinical systems” ...
With support from the government of Ontario, Piramal Pharma is investing $5,314,000 to upgrade site infrastructure at their ...
Japan’s Chugai Pharmaceutical and InxMed (Hong Kong) have entered into a worldwide license agreement regarding SPYK04, a ...
The Faculty of Computer and Mathematical Sciences (FCMS) of The Hong Kong Polytechnic University (PolyU) and the Institute of ...
Telix recently completed enrollment in the Phase 3 BiPASS study of its proprietary 68Ga-PSMA-PET agents, Illuccix® and Gozellix® for pre-biopsy prostate cancer diagnosis. The ompany has positively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results